Biopharma Manufacturing Market By Application: Biologic Production, Process Development, By End-Use: Biopharmaceutical Companies, Research Institutions, By Region: North America, Europe, Asia Pacific, Segment Forecasts: 2024 - 2030
Biopharma Manufacturing Market Trends
The biopharma manufacturing market was valued at USD 274.1 billion in 2024 and is projected to grow at a CAGR of 9.2% from 2025 to 2030. The increasing demand for biopharmaceuticals is driving growth in manufacturing capabilities and technologies.
Product Insights
Biologic production applications represented the largest market segment in 2024, accounting for 63.7% of total revenue. Process development applications are also gaining traction, as companies seek to optimize their production methods for biologics.
End-Use Insights
Biopharmaceutical companies held the largest share in 2024, capturing 68.4% of the market, as they expand their manufacturing capabilities to meet rising demand. Research institutions are also utilizing biopharma manufacturing services for innovative research projects.
Regional Insights
North America dominated the biopharma manufacturing market with a 52.9% share in 2024, supported by a strong biotech sector and high investments in manufacturing technologies. The Asia Pacific region is expected to grow rapidly, with a CAGR of 10.5%, as manufacturing infrastructure improves.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.